←Cardiology & EP
Aortic stenosis on the wards
📚
📚 Library › ❤️ Cardiology & EP › Valves & endocarditis
🚪

Aortic stenosis on the wards

Grading severity, the "fixed door" rules for fluids, pressors and sedation, TAVR vs SAVR, and the asymptomatic-AS debate.

aortic stenosisTAVRSAVRlow-flow low-gradientHeyde
🗓️ Reviewed 2026-11-19 · ⏱️ 6 min read · 📖 2020 ACC/AHA valvular heart disease guideline · 2025 ESC/EACTS valvular heart disease guideline · 2024 ACC/AHA perioperative guideline · EARLY TAVR trial
🧠 Pathophysiology in 60 seconds🔎 Diagnosis🧪 Workup💊 Management⚠️ Pitfalls🎓 Board corner📚 References
⚡ Bottom line — first hour
  • Symptoms of severe AS = angina, syncope, dyspnea/HF (or lower exercise tolerance). Once symptoms start, survival drops fast without valve replacement.
  • Severe AS: Vmax ≥4 m/s, mean gradient ≥40 mmHg, AVA ≤1.0 cm² (AVAi ≤0.6). Discordant numbers → low-flow work-up.
  • Symptomatic severe AS → AVR (TAVR or SAVR) — Class 1 in all guidelines. Heart Team decides the route.
  • Ward rules — "fixed door": keep preload (gentle diuresis), keep HR slow and sinus rhythm, avoid big vasodilator drops; hypotension → phenylephrine or norepinephrine.
  • Decompensated and too sick for AVR → balloon aortic valvuloplasty as a bridge.
  • GI bleeding from angiodysplasia + AS = Heyde syndrome → AVR often stops it.

🧠 Pathophysiology in 60 seconds

⌄
Systole →Pressure gradient LVAorta
⛽Keep the tank fullPreload-dependent. Diurese gently. Treat bleeding and vomiting fast.
🐢Keep the rate slowTachycardia shortens diastole → less filling and coronary flow. AF poorly tolerated.
🎯Keep the afterload upBig vasodilator drops (nitro, hydralazine, sedation) → BP crash. Hypotension → phenylephrine or norepinephrine.
🎻Keep the rhythmThe stiff LV needs the atrial kick. Cardiovert unstable AF early.

A calcified valve is a fixed, narrow door. The LV must push much harder (the shaded gap is the gradient). Cardiac output cannot rise much — so anything that drops filling or BP can cause collapse.

  • Calcified (age, bicuspid valve) or rheumatic leaflets → fixed obstruction to outflow.
  • LV adapts with concentric hypertrophy → stiff, preload-dependent ventricle that needs the atrial kick.
  • Angina: thick muscle needs more O₂, while high LV pressure squeezes the coronaries and diastole is short.
  • Syncope: on exertion, muscles vasodilate but cardiac output cannot rise through the narrow valve → BP falls.
  • HF: high filling pressures (diastolic dysfunction), later the LV fails (low EF).

🔎 Diagnosis

⌄

Exam: harsh crescendo–decrescendo systolic murmur at the right upper sternal border → carotids · later peak = more severe · soft or absent S2 · pulsus parvus et tardus (weak, late carotid upstroke) · S4.

Stage Vmax Mean gradient AVA
Mild 2.0–2.9 m/s <20 mmHg >1.5 cm²
Moderate 3.0–3.9 m/s 20–39 mmHg 1.0–1.5 cm²
Severe ≥4.0 m/s ≥40 mmHg ≤1.0 cm²
Very severe ≥5.0 m/s ≥60 mmHg —

AVA ≤1.0 cm² but gradient <40 mmHg. Is the valve really tight, or is the LV too weak to open it?

Type Next test
Low EF (<50%) — "classical" Low-dose dobutamine echo: gradient rises ≥40 with AVA staying ≤1.0 → true severe AS. AVA opens up → pseudo-severe
Normal EF, SVi <35 mL/m² — "paradoxical" (small, thick LV; often HTN, women, AF) CT aortic valve calcium score: severe likely ≥2000 AU men / ≥1200 AU women; very likely ≥3000 / ≥1600
  • HCM (LVOT obstruction): murmur louder with Valsalva/standing, softer with squatting; normal carotid upstroke (brisk, bifid).
  • Aortic sclerosis: murmur without gradient (Vmax <2.5 m/s).
  • Mitral regurgitation: holosystolic at the apex → axilla.
  • Subvalvular/supravalvular stenosis (young patients) → echo.

🧪 Workup

⌄
  • TTE (severity, EF, other valves). Repeat if symptoms change.
  • ECG (LVH, AF, conduction disease), BNP (prognosis), CBC (Heyde).
  • Cardiac CT (TAVR protocol) and coronary evaluation (cath or CT) before AVR.
  • Exercise testing only in truly asymptomatic patients — never in symptomatic severe AS.
  • Consider ATTR cardiac amyloid in older patients with low-flow AS (common overlap) → PYP scan + light chains.

💊 Management

⌄
Problem Do Avoid
Volume overload Gentle loop diuretic, daily weights Over-diuresis → preload crash
Hypotension / sepsis Fluids in small boluses + phenylephrine or norepinephrine Dobutamine/milrinone alone (vasodilate) — unless low-EF AS under expert care
AF with RVR Early cardioversion if unstable; rate control carefully Large IV diltiazem pushes in a hypotensive patient
Hypertension Start low, go slow (ACEi/ARB OK) Big drops with nitro/hydralazine drips
Sedation / intubation Etomidate or small doses, pressor ready Large propofol bolus
Neuraxial anesthesia Discuss with anesthesia Rapid sympathectomy
  • AVR indicated (Class 1): symptomatic severe AS · asymptomatic severe AS with EF <50% · severe AS having other cardiac surgery.
  • Reasonable: very severe AS (Vmax ≥5), abnormal exercise test, rapid progression, high BNP — in low-risk patients.
  • TAVR vs SAVR (Heart Team + shared decision):
  • ACC/AHA 2020: >80 y → TAVR, 65–80 → either, <65 → SAVR (anatomy, life expectancy, bicuspid valve matter).
  • ESC/EACTS 2025: TAVI for age ≥70 with a tricuspid valve and suitable anatomy, whatever the surgical risk.
  • Balloon valvuloplasty: bridge in shock or before urgent noncardiac surgery.
  • Palliative care when AVR is not in the patient's goals or life expectancy is <1 year.
  • EARLY TAVR (2024): early TAVR vs surveillance in asymptomatic severe AS → fewer deaths, strokes or unplanned CV hospitalizations (driven by hospitalizations); many in the surveillance arm needed AVR within ~2 years.
  • ESC/EACTS 2025 now supports early intervention in selected asymptomatic patients with severe high-gradient AS and normal EF if procedural risk is low.
  • US: the 2020 ACC/AHA guideline predates EARLY TAVR. CMS (2026) still covers TAVR for asymptomatic AS only within approved studies. Expect change — check for a US update.
  • Either way: ask about symptoms carefully — many "asymptomatic" patients have quietly slowed down.
  • Symptomatic severe AS + elective surgery → AVR (often TAVR) first.
  • Asymptomatic severe AS → elevated-risk elective surgery is reasonable with invasive monitoring, careful volume, avoid tachycardia and hypotension.
  • Urgent surgery → proceed with anesthesia/cardiology plan; BAV in selected cases.
💡 Pearl

No drug slows AS. Statins did not work (SEAS, ASTRONOMER, SALTIRE) — treat lipids for atherosclerosis, not for the valve.

⚠️ Pitfalls

⌄
  • Calling it "flow murmur" in an older patient with syncope.
  • Aggressive diuresis or nitro drip → sudden hypotension and arrest.
  • Missing low-flow, low-gradient severe AS because "the gradient is only 30."
  • Treating GI bleeding again and again without thinking of Heyde syndrome.
  • Missing ATTR amyloid alongside AS in elderly patients.

🎓 Board corner

⌄
Stem Answer
78-year-old, exertional syncope, late-peaking murmur, soft S2 Severe AS → TTE → AVR
Severe AS, EF 25%, gradient 25, AVA 0.8 Low-flow AS → dobutamine echo
Murmur louder with Valsalva, quieter with squatting HCM (not AS)
AS + recurrent GI bleeding from angiodysplasia Heyde syndrome (acquired vWF deficiency) → AVR
Severe AS patient becomes hypotensive after sedation Phenylephrine / norepinephrine
84-year-old with symptomatic severe AS, suitable anatomy TAVR
55-year-old, bicuspid valve, symptomatic severe AS, low risk SAVR

📚 References

⌄
  • Otto CM, et al. 2020 ACC/AHA guideline for the management of valvular heart disease. Circulation. 2021;143:e72.
  • Praz F, et al. 2025 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2025. doi:10.1093/eurheartj/ehaf194.
  • Généreux P, et al. TAVR for asymptomatic severe aortic stenosis (EARLY TAVR). N Engl J Med. 2025;392:217.
  • Thompson A, et al. 2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM guideline for perioperative cardiovascular management for noncardiac surgery. Circulation. 2024;150:e351.
  • CMS. TAVR National Coverage Determination, 2026 update.
  • MGH White Book 2019–2020: Valvular heart disease (structure).
↩︎ Back to ❤️ Cardiology & EP